| Literature DB >> 35736178 |
Zhiguo Liu1, Li Liu1, Anqi Wang1, Li Li2, Sinan Zhao1, Yanan Wang2, Yi Sun1.
Abstract
Five novel tyrosine-decahydrofluorene analogues, xenoacremones D-H (1-5), each bearing a fused 6/5/6 tricarbocyclic core and a 13-membered para-cyclophane ring system, were isolated from the endophytic fungus Xenoacremonium sinensis. Compound 1 was a novel polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) tyrosine-decahydrofluorene hybrid containing a 6/5/6/6/5 ring system. Their structures were elucidated from comprehensive spectroscopic analysis and electronic circular dichroism (ECD) calculations. All compounds were evaluated for their inhibitory activities on LPS-induced NO production in macrophages and their cytotoxicities against the NB4 and U937 cell lines. Compounds 3 and 5 exhibited potent anti-inflammatory activities in vitro. Compounds 1 and 3-5 displayed significant antiproliferative activity against the tumor cell lines (IC50 < 20 µM).Entities:
Keywords: Xenoacremonium sinensis; anti-inflammatory; cytotoxic activity; endophytic fungus; tyrosine-decahydrofluorene
Mesh:
Substances:
Year: 2022 PMID: 35736178 PMCID: PMC9227518 DOI: 10.3390/md20060375
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Structures of compounds 1–5.
1H NMR (600 MHz) and 13C NMR data of compounds 1–5 in CD3OD.
| 1 | 2 | 3 | 4 | 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. |
|
|
|
|
| |||||
| 1 | 49.9 | Hα: 1.38, t (12.2) | 119.0 | 4.90, d (17.0) | 119.2 | 4.91, d (17.1) | 117.6 | 4.88, m | 116.7 | 5.07, d (10.6) |
| 2 | 64.6 | 5.16, dd (12.2, 6.0) | 134.8 | 5.30, dd (16.8, 9.0) | 139.0 | 5.77, ddd (17.1, 10.4, 5.7) | 140.7 | 5.71, dd (17.0, 9.6) | 137.9 | 5.80, ddd (17.5, 10.4, 7.1) |
| 3 | 48.9 | 2.86, m | 48.7 | 2.56, m | 43.8 | 3.33, m | 46.8 | 2.42, m | 43.1 | 2.90, m |
| 4 | 125.8 | 5.60, dd (9.1, 3.3) | 68.8 | 3.84, dd (4.2, 1.2) | 127.7 | 5.25, dd (9.6, 4.6) | 130.5 | 5.65, dd (9.0, 4.2) | 126.9 | 5.61, dd (9.0, 3.1) |
| 5 | 132.8 | 6.02, dd (9.1, 3.0) | 118.0 | 5.56, d (1.2) | 130.6 | 6.01, d (9.6) | 133.4 | 5.95, d (9.0) | 133.0 | 6.24, dd (9.0, 2.9) |
| 6 | 46.5 | 1.45, m | 148.7 | 41.8 | 2.97, m | 44.0 | 2.19, m | 43.1 | 1.64, m | |
| 7 | 46.3 | 1.51, m | 46.3 | 2.63, m | 42.7 | 2.24, m | 48.1 | 1.91, m | 48.5 | 1.53, m |
| 8 | 39.4 | Hα: 2.01, m | 39.5 | Hα: 2.09, m | 38.6 | Hα: 1.97, m | 41.1 | Hα: 2.10, m | 38.7 | Hα: 2.01, m |
| 9 | 33.9 | 1.52, m | 34.6 | 1.63, m | 35.5 | 1.61, m | 34.1 | 1.57, m | 32.4 | 1.55, m |
| 10 | 46.7 | Hα: 1.80, m | 45.9 | Hα: 1.76, m | 46.5 | Hα: 1.76, m | 45.4 | Hα: 1.76, m | 45.1 | Hα: 1.78, m |
| 11 | 33.1 | 1.89, m | 32.9 | 1.78, m | 33.8 | 1.74, m | 32.4 | 1.78, m | 31.5 | 1.87, m |
| 12 | 58.3 | 1.20, m | 57.0 | 1.10, m | 61.7 | 1.01, m | 57.5 | 1.03, m | 57.7 | 1.05, m |
| 13 | 86.6 | 4.75, dd (8.3, 6.5) | 80.4 | 4.98, m | 82.4 | 5.04, m | 83.2 | 4.65, t (3.4) | 88.7 | 4.47, dd (7.7, 4.9) |
| 14 | 51.7 | 2.13, m | 46.8 | 2.64, m | 47.5 | 1.79, m | 49.8 | 2.70, m | 54.3 | 1.95, m |
| 15 | 45.8 | 3.57, dd (7.9, 6.8) | 46.4 | 2.45, dd (11.4, 3.6) | 50.4 | 2.68, dd (10.2, 5.4) | 51.8 | 2.45, dd (10.8, 6.6) | 49.5 | 3.80, t (8.0) |
| 16 | 202.4 | 201.9 | 206.1 | 203.2 | 201.6 | |||||
| 17 | 60.5 | - | 60.8 | - | 81.1 | - | 134.8 | - | 56.5 | 3.12, dd (12.2, 4.2) |
| 18 | 177.0 | 169.3 | 175.9 | 170.6 | 172.3 | |||||
| 19 | 22.9 | 0.96, d (6.6) | 22.7 | 0.98, d (6.6) | 22.9 | 0.97, d (6.6) | 22.8 | 0.99, d (6.6) | 22.6 | 0.94, d (6.5) |
| 20 | 20.7 | 1.11, d (6.3) | 20.0 | 1.07, d (6.6) | 20.1 | 1.05, d (6.6) | 20.4 | 1.06, d (6.6) | 20.1 | 1.09, d (6.2) |
| 1’ | 42.8 | Hα: 2.97, d (14.0) | 65.0 | 3.60, s | 39.4 | Hα: 2.17 d (16.2) | 153.7 | 6.44, s | 34.6 | Hα: 2.85, dd (15.0, 4.2) |
| 2’ | 88.9 | 84.9 | 92.5 | 89.3 | 88.2 | |||||
| 3’ | 46.7 | Hα: 2.99, d (13.4) | 46.1 | Hα: 3.32, d (13.2) | 45.1 | Hα: 3.15, d (13.5) | 45.8 | Hα: 3.26, d (12.6) | 46.9 | Hα: 2.95, d (13.1) |
| 4’ | 129.4 | 129.7 | 132.5 | 129.7 | 128.4 | |||||
| 5’ | 133.7 | 6.95, dd (8.4, 1.8) | 130.4 | 7.08, dd (8.4, 1.8) | 131.0 | 6.97, dd (8.4, 2.4) | 129.7 | 6.94, dd (8.4, 1.8) | 133.4 | 6.98, dd (8.4, 2.0) |
| 6’ | 121.0 | 6.70, dd (8.4, 2.4) | 120.0 | 6.91, dd (8.4, 2.4) | 123.5 | 6.84, dd (8.4, 2.4) | 119.0 | 6.90, dd (8.4, 2.4) | 124.3 | 6.74, dd (7.8,1.8) |
| 7’ | 159.1 | 160.6 | 159.7 | 162.0 | 157.9 | |||||
| 8’ | 125.2 | 6.94, dd (8.4, 2.4) | 13.8 | 7.03, dd (8.4, 2.4) | 123.3 | 7.02, dd (8.4, 2.4) | 123.1 | 6.84, dd (8.4, 2.4) | 120.2 | 7.02, dd (8.4, 1.8) |
| 9’ | 134.0 | 6.96, dd (8.4, 1.8) | 134.1 | 7.29, dd (8.4, 2.4) | 133.4 | 7.16, dd (8.4, 2.4) | 133.0 | 7.28, dd (8.4, 2.4) | 131.9 | 7.07, dd (7.8, 2.0) |
| 10’ | 49.7 | 3.24, s | - | - | - | - | ||||
Data were recorded in CD3OD; Data were recorded in CDCl3.
Figure 2Key HMBC and 1H-1H COSY correlations of compounds 1–5.
Figure 3Key NOE correlations of compounds 1–3.
Figure 4Experimental and calculated ECD of compounds 1–3 (in MeOH).
Inhibitory effects of compounds 1–5 on NO production in LPS-induced RAW264.7 cells .
| 1 | 2 | 3 | 4 | 5 | Resveratrol | |
|---|---|---|---|---|---|---|
| IC50± SD (μM) | 45.8 ± 0.5 | 37.5 ± 0.4 | 12.8 ± 0.3 | -- | 6.7 ± 0.3 | 36.0 ± 0.4 |
Resveratrol and DMSO were used as the positive and negative control, respectively. “--” denotes IC50 value ˃ 50 μM.
Cytotoxicities of compounds 1–5 (IC50 values: μM) .
| Compound | NB4 | U937 |
|---|---|---|
|
| 12.6 ± 0.2 | 13.9 ± 0.3 |
|
| -- | -- |
|
| 18.4 ± 0.4 | 13.5 ± 0.1 |
|
| 11.9 ± 0.2 | 8.5 ± 0.2 |
|
| 6.4 ± 0.1 | 10.6 ± 0.2 |
| Adriamycin | 0.4 ± 0.1 | 0.2 ± 0.1 |
Adriamysin and DMSO were used as the positive and negative control, respectively. “--” denotes IC50 value ˃ 20 μM.